Quest Diagnostics DGX Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Quest Diagnostics’s reported figures.
Based on trailing twelve months.
The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →
Ask your AI about Quest Diagnostics's return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Quest Diagnostics's return on assets?
- Quest Diagnostics (DGX) reported return on assets of 6.3% in Q1 2026.
- How has Quest Diagnostics's return on assets changed year-over-year?
- Quest Diagnostics's return on assets increased by 4.6% year-over-year, from 6% to 6.3%.
- What is the long-term trend for Quest Diagnostics's return on assets?
- Over 4 years (2021 to 2025), Quest Diagnostics's return on assets has grown at a -20.5% compound annual growth rate (CAGR), from 61.4% to 24.5%.
- What does return on assets mean?
- How much profit the company squeezes out of everything it owns.
- How do you interpret return on assets?
- Higher means more productive assets. Unlike ROE, it is unaffected by leverage, so a wide ROE-minus-ROA gap flags a heavily levered balance sheet.
- How does return on assets compare across companies?
- Best compared within an industry — asset intensity varies enormously across sectors. Not meaningful for banks, whose assets are largely financial.